125 related articles for article (PubMed ID: 11167821)
41. Clinical characteristics and treatment outcome of children with acute lymphocytic leukemia and Down's syndrome. A Pediatric Oncology Group study.
Ragab AH; Abdel-Mageed A; Shuster JJ; Frankel LS; Pullen J; van Eys J; Sullivan MP; Boyett J; Borowitz M; Crist WM
Cancer; 1991 Feb; 67(4):1057-63. PubMed ID: 1825025
[TBL] [Abstract][Full Text] [Related]
42. Fatal adenovirus hepatitis during standard chemotherapy for childhood acute lymphoblastic leukemia.
Hough R; Chetwood A; Sinfield R; Welch J; Vora A
J Pediatr Hematol Oncol; 2005 Feb; 27(2):67-72. PubMed ID: 15701979
[TBL] [Abstract][Full Text] [Related]
43. Patterns of care and survival for children with acute lymphoblastic leukaemia diagnosed between 1980 and 1994.
Stiller CA; Eatock EM
Arch Dis Child; 1999 Sep; 81(3):202-8. PubMed ID: 10451391
[TBL] [Abstract][Full Text] [Related]
44. Excellent outcome of minimal residual disease-defined low-risk patients is sustained with more than 10 years follow-up: results of UK paediatric acute lymphoblastic leukaemia trials 1997-2003.
Bartram J; Wade R; Vora A; Hancock J; Mitchell C; Kinsey S; Steward C; Moppett J; Goulden N
Arch Dis Child; 2016 May; 101(5):449-54. PubMed ID: 26865705
[TBL] [Abstract][Full Text] [Related]
45. Improved outcome of acute myeloid leukaemia in Down's syndrome.
Craze JL; Harrison G; Wheatley K; Hann IM; Chessells JM
Arch Dis Child; 1999 Jul; 81(1):32-7. PubMed ID: 10373130
[TBL] [Abstract][Full Text] [Related]
46. Improvements in outcome of childhood acute lymphoblastic leukaemia (ALL) in the UK - a success story of modern medicine through successive UKALL trials and international collaboration.
Bartram J; Veys P; Vora A
Br J Haematol; 2020 Nov; 191(4):562-567. PubMed ID: 33190256
[TBL] [Abstract][Full Text] [Related]
47. Treatment-related deaths during induction and first remission of acute myeloid leukaemia in children treated on the Tenth Medical Research Council acute myeloid leukaemia trial (MRC AML10). The MCR Childhood Leukaemia Working Party.
Riley LC; Hann IM; Wheatley K; Stevens RF
Br J Haematol; 1999 Aug; 106(2):436-44. PubMed ID: 10460604
[TBL] [Abstract][Full Text] [Related]
48. Induction death and treatment-related mortality in first remission of children with acute lymphoblastic leukemia: a population-based analysis of the Austrian Berlin-Frankfurt-Münster study group.
Prucker C; Attarbaschi A; Peters C; Dworzak MN; Pötschger U; Urban C; Fink FM; Meister B; Schmitt K; Haas OA; Gadner H; Mann G;
Leukemia; 2009 Jul; 23(7):1264-9. PubMed ID: 19212332
[TBL] [Abstract][Full Text] [Related]
49. The UK experience in treating relapsed childhood acute lymphoblastic leukaemia: a report on the medical research council UKALLR1 study.
Lawson SE; Harrison G; Richards S; Oakhill A; Stevens R; Eden OB; Darbyshire PJ
Br J Haematol; 2000 Mar; 108(3):531-43. PubMed ID: 10759711
[TBL] [Abstract][Full Text] [Related]
50. Acute lymphoblastic leukemia and Down syndrome: presenting features and treatment outcome in the experience of the Italian Association of Pediatric Hematology and Oncology (AIEOP).
Arico M; Ziino O; Valsecchi MG; Cazzaniga G; Baronci C; Messina C; Pession A; Santoro N; Basso G; Conter V;
Cancer; 2008 Aug; 113(3):515-21. PubMed ID: 18521927
[TBL] [Abstract][Full Text] [Related]
51. Risk factors for treatment related mortality in childhood acute lymphoblastic leukaemia.
Lund B; Åsberg A; Heyman M; Kanerva J; Harila-Saari A; Hasle H; Söderhäll S; Jónsson ÓG; Lydersen S; Schmiegelow K;
Pediatr Blood Cancer; 2011 Apr; 56(4):551-9. PubMed ID: 21298739
[TBL] [Abstract][Full Text] [Related]
52. Mercaptopurine in childhood leukaemia: the effects of dose escalation on thioguanine nucleotide metabolites.
Lennard L; Welch J; Lilleyman JS
Br J Clin Pharmacol; 1996 Oct; 42(4):525-7. PubMed ID: 8904630
[TBL] [Abstract][Full Text] [Related]
53. Role of infection in the death of children with acute lymphoblastic leukaemia.
Craft AW; Reid MM; Bruce E; Kernahan J; Gardner PS
Arch Dis Child; 1977 Oct; 52(10):752-7. PubMed ID: 270964
[TBL] [Abstract][Full Text] [Related]
54. Polymerase chain reaction (PCR)- and reverse transcription PCR-based minimal residual disease detection in long-term follow-up of childhood acute lymphoblastic leukaemia.
Gameiro P; Moreira I; Yetgin S; Papaioannou M; Potter MN; Prentice HG; Hoffbrand AV; Foroni L
Br J Haematol; 2002 Dec; 119(3):685-96. PubMed ID: 12437645
[TBL] [Abstract][Full Text] [Related]
55. [Treatment failure in children with acute myelocytic leukemia: over 25-year experience of Polish Pediatric Leukemia/Lymphoma Study Group with four consecutive unified treatment protocols for childhood acute myelocytic leukemia].
Dłuzniewska A; Balwierz W; Balcerska A; Chybicka A; Kamieńska E; Karolczyk G; Karpińska-Derda I; Krawczuk-Rybak M; Kowalczyk JR; Lewandowska D; Maciejka-Kapuścińska L; Kołtano S; Malinowska I; Matysiak M; Mikołajczyk M; Mizia-Malarz A; Muszyńska-Rosłan K; Niedźwiedzki M; Pohorecka J; Sikorska-Fic B; Sobol G; Sońta-Jakimczyk D; Tomaszewska R; Urasiński T; Wachowiak J; Wieczorek M; Wójcik B; Wysocki M
Przegl Lek; 2010; 67(6):366-70. PubMed ID: 21344763
[TBL] [Abstract][Full Text] [Related]
56. Chemotherapy versus allogeneic transplantation for very-high-risk childhood acute lymphoblastic leukaemia in first complete remission: comparison by genetic randomisation in an international prospective study.
Balduzzi A; Valsecchi MG; Uderzo C; De Lorenzo P; Klingebiel T; Peters C; Stary J; Felice MS; Magyarosy E; Conter V; Reiter A; Messina C; Gadner H; Schrappe M
Lancet; 2005 Aug 20-26; 366(9486):635-42. PubMed ID: 16112299
[TBL] [Abstract][Full Text] [Related]
57. Prognostic importance of myelosuppression during maintenance treatment of lymphoblastic leukaemia. Leukaemia in Childhood Working Party of the Medical Research Council.
Dolan G; Lilleyman JS; Richards SM
Arch Dis Child; 1989 Sep; 64(9):1231-4. PubMed ID: 2684039
[TBL] [Abstract][Full Text] [Related]
58. [Early deaths and intensification of the treatment of acute lymphoblastic leukemia in children].
Rytlewska M; Kubiczek K; Tretowska D
Pol Tyg Lek; 1988 Jul; 43(28):910-2. PubMed ID: 3247261
[No Abstract] [Full Text] [Related]
59. Prognostic factors influencing infection-related mortality in patients with acute leukemia in Korea.
Yoo JH; Choi SM; Lee DG; Choi JH; Shin WS; Min WS; Kim CC
J Korean Med Sci; 2005 Feb; 20(1):31-5. PubMed ID: 15716598
[TBL] [Abstract][Full Text] [Related]
60. Pneumocystis jiroveci pneumonia prophylaxis during maintenance therapy influences methotrexate/6-mercaptopurine dosing but not event-free survival for childhood acute lymphoblastic leukemia.
Levinsen M; Shabaneh D; Bohnstedt C; Harila-Saari A; Jonsson OG; Kanerva J; Lindblom A; Lund B; Andersen EW; Schmiegelow K;
Eur J Haematol; 2012 Jan; 88(1):78-86. PubMed ID: 21854453
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
